An exactly solvable model based on the topology of a protein native state is applied to identify bottlenecks and key sites for the folding of human immunodeficiency virus type 1 (HIV-1) protease. The predicted sites are found to correlate well with clinical data on resistance to Food and Drug Administration-approved drugs. It has been observed that the effects of drug therapy are to induce multiple mutations on the protease. The sites where such mutations occur correlate well with those involved in folding bottlenecks identified through the deterministic procedure proposed in this study. The high statistical significance of the observed correlations suggests that the approach may be promisingly used i...
<div><p>Predicting which mutations proteins tolerate while maintaining their structure and function ...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the...
Human immunodeficiency virus type 1 protease (HIV-1 PR) is an essential enzyme in the HIV-1 life cy...
An exactly solvable model based on the topology of a protein native state is applied to identify...
An exactly solvable model based on the topology of a protein native state is applied to identify bot...
Drug resistance to HIV-1 protease involves the accumulation of multiple mutations in the protein...
involves the accumulation of multiple mutations in the protein. We investigate the role of these mut...
Drug resistance to HIV-1 protease involves the accumulation of multiple mutations in the protein. We...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) plays an essential role in the life cycle ...
The evolution of drug resistance in HIV has been a major obstacle in combating the AIDS epidemic, an...
General physical principles have taught us that, good folders are those sequences of amino acids whi...
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of a...
but with only one active site. The active-site triad (Asp-Knowledge of the polyprotein cleavage site...
The protease from type I human immunodeficiency virus (HIV-1 ) is a critical drug target against whi...
A novel way to inhibit HIV-1 protease by destabilizing its native state is discussed. A simplified p...
<div><p>Predicting which mutations proteins tolerate while maintaining their structure and function ...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the...
Human immunodeficiency virus type 1 protease (HIV-1 PR) is an essential enzyme in the HIV-1 life cy...
An exactly solvable model based on the topology of a protein native state is applied to identify...
An exactly solvable model based on the topology of a protein native state is applied to identify bot...
Drug resistance to HIV-1 protease involves the accumulation of multiple mutations in the protein...
involves the accumulation of multiple mutations in the protein. We investigate the role of these mut...
Drug resistance to HIV-1 protease involves the accumulation of multiple mutations in the protein. We...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) plays an essential role in the life cycle ...
The evolution of drug resistance in HIV has been a major obstacle in combating the AIDS epidemic, an...
General physical principles have taught us that, good folders are those sequences of amino acids whi...
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of a...
but with only one active site. The active-site triad (Asp-Knowledge of the polyprotein cleavage site...
The protease from type I human immunodeficiency virus (HIV-1 ) is a critical drug target against whi...
A novel way to inhibit HIV-1 protease by destabilizing its native state is discussed. A simplified p...
<div><p>Predicting which mutations proteins tolerate while maintaining their structure and function ...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the...
Human immunodeficiency virus type 1 protease (HIV-1 PR) is an essential enzyme in the HIV-1 life cy...